Outsourcing Clinical Trials West Coast

One of the keys to a successful trial is having a transparent relationship between sponsor and service provider. Please join the Clinical Maestro team and learn how to streamline this process, reducing your effort, and increasing your confidence. Join our CEO, Anca Copaescu, as she chairs, moderates and presents on the hot topics around clinical outsourcing.

Burlingame, CA
United States
15^th – 16^th February 2022

DAY 1: February 15th

11:00am Anca Copaescu, CEO Strategikon, Chair Stream B (Tech & Innovation)

12:30 Panel Discussion: Decentralized/Hybrid Trials: Discussing the current challenges and debating best practices for a successful virtual study 

Building a company’s internal virtual trial eco-system is key to making decentralized trials happen – the panel will give advice on best practices.

Are hybrid models superior to 100% virtualized? Considering the challenges with retaining patients and investigators in these new virtual trial designs.

Patient Bias – Decentralized trials require patients to have reliable internet service, etc. Could this induce a bias for which patients are recruited in fully virtual trials?
Debating strategies for overcoming challenges with virtual trials, such as missing adverse reactions if done remotely, and wearable device integration

• Moderator: Anca Copaescu, CEO, Strategikon
• Michael Cox, Global Outsourcing Director, Ascendis Pharma
• Mark J. Milberg, Senior Director, Clinical Outsourcing, Ultragenyx Pharmaceutical
• Michael Tucker, Senior Product Solutions Specialist, Medidata Solutions
• Alfonso Coro, Director, Project Management, SDC

2:00pm Fireside Chat: ‘Regenerative Medicine as a Future Trend’; Moderated by Anca Copaescu, CEO, Strategikon

Bai Xu, CEO, Nanomed

DAY 2: February 16th 

9:00am Anca Copaescu, CEO Strategikon, Chair Stream B (Tech & Innovation)

10:00 A Fireside Chat on…. The Budget Conundrum; Moderated by Anca Copaescu, CEO, Strategikon 

Demystifying site budget and contracting processes to improve financial transparency between sites, sponsors and vendors

 Stephanie Molteni, Director, Site Budgets & Contract Management, Ultragenyx Pharmaceutical

12:15pm Q&A after –‘Planning for success: Regulatory and quality compliance for novel products’; Moderated by Anca Copaescu, CEO, Strategikon

Vinaya Kapoor, VP, Tricida, Inc.

1:45pm Panel discussion: Defining your outsourcing strategy to contain costs and accelerate drug development time-to-market: what should you consider in the new COVID-19 era

• Moderator: Anca Copaescu, CEO, Strategikon
• Laurin Vincent, Head, Supplier Performance Management, Genentech/Roche
• Gabriel Luciano, Executive Director, Clinical Operations, Corvus Pharmaceuticals
• Donald J Kellerman, Vice President, Clinical Development and Medical Affairs, Zosano Pharma
• Meraf Eyassu, Senior Director, Clinical Operations, FibroGen, Inc.